Captopril Shortage Alert

August 17, 2026

on Facebook, opens in a new window
on Twitter, opens in a new window
on Linkedin, opens in a new window
via email, opens in a new window

Supply of captopril tablets is limited following the discontinuation of Teva’s products and ongoing manufacturing disruptions affecting several Apotex strengths.

The Canadian Cardiovascular Society is collaborating with a number of national organizations on a captopril resource for healthcare professionals:

Captopril Shortage Resource

We will continue to update you on this important issue as we learn more.

If you have any questions or concerns related to the shortage of captopril, please contact communications@ccs.ca.